In this podcast, Susan Chang, MD, highlights and explains research on brain tumors and what it means for patients and their families.
Jeffrey Meyerhardt, MD, shares research highlights from the 2015 ASCO Annual Meeting on gastrointestinal cancers.
In March 2013, John’s wife Lori found a lump in her breast. Lori, a radiation oncologist, soon went from giving cancer care to receiving it. In this guest post, John talks about how to navigate a cancer diagnosis, a journey for which we are all ill-prepared.
Next in our Research Round Up series, Robert Maki, MD, and Melissa Hudson, MD, share research on sarcoma and childhood cancers.
Expert-led podcasts explaining research on kidney cancer and melanoma, featuring Brian I. Rini, MD, and Paul Chapman, MD.
First in our summer Research Round Up podcast series, Charles Loprinzi, MD, and Ezra Cohen, MD, unpack some of science highlights from the 2015 ASCO Annual Meeting.
In January, Randy Hillard was part of the U.S. Food and Drug Administration committee that considered the first application for a “biosimilar” medication. In this guest post, he describes patients’ role in the drug approval process and how the committee’s decision could influence cancer care in the future.
In this podcast, experts Charles Ryan, MD, and Thomas Powles, MD, talk about bladder cancer treatment, including some of the new approaches that are being developed.
Two out of three people now live at least five years after being diagnosed with cancer, but there is still more to be done. Researchers at the 2015 ASCO Annual Meeting showed how new treatment options can continue to improve and lengthen the lives of people with both rare and common cancers.
Is More Extensive Surgery Better for Early-Stage Oral Cancer? – Research from the 2015 ASCO Annual Meeting
Doctors worldwide have struggled with this question for decades. A new study presented today at the 2015 ASCO Annual Meeting provides clarification on whether lymph nodes should be removed before or after cancer has been detected in the nodes of people with early-stage oral cancer.